GLP-1-boosting fibre approved as safe by European regulator, could be added to foods within a year
By
Michael Le Page
Summary
A novel form of fibre that stimulates the release of hunger-reducing hormones like GLP-1 (similar to drugs such as Wegovy and Ozempic) has been approved as safe by the European Food Safety Authority. Developed by researchers at Imperial College London, the fibre could be added to foods like breads, smoothies, and cereals within the next year. A randomised-controlled trial showed it prevents weight gain in middle-aged people when consumed daily. The fibre works by triggering GLP-1 release in the gut, helping to reduce appetite and food intake without the need for injections or medication.
Source
Key quotes
· 2 pulledWe showed in a randomised-controlled trial in middle-aged people that when it's consumed daily, it prevents weight gain
In young people, although you don't see the impact on body weight,
You might also wanna read
Experts warn easy access to GLP-1 drugs may increase eating disorder risks
Experts are raising concerns that the widespread availability of GLP-1 drugs (like Ozempic and Wegovy) through telemedicine and oral formula
Food Noise Gains Scientific Recognition as a Treatable Phenomenon
"Food noise" — the constant, unwanted preoccupation with food — is gaining recognition as a real, measurable phenomenon. Patients have descr
Study Finds GLP-1 Drugs Associated with 58% Lower Mortality in Colon Cancer Patients
A study analyzing over 6,800 colon cancer patients across University of California Health sites found that patients taking GLP-1 medications
What GLP-1 Drugs Reveal About the Brain's Compulsive Urges
GLP-1 medications (like Ozempic, Wegovy) are revealing insights about compulsive behavior beyond their effects on appetite. Patients report

Novo Nordisk launches first GLP-1 weight loss pill Wegovy in US at lower price than injections
Novo Nordisk has launched the first pill version of its blockbuster GLP-1 weight loss drug Wegovy in the US at a significantly lower price t
Systematic Review Finds GLP-1 Agonists Do Not Harm Male Fertility, May Offer Benefits
A systematic review presented at a medical conference found that GLP-1 agonists (like Ozempic, Wegovy) do not harm male fertility or the mal

Comments
Sign in to join the conversation.
No comments yet. Be the first.